Comparison of the Two and Six- Minute Walk Tests in Evaluating Oxygen Desaturation in Patients With Severe COPD

Sponsor
Schön Klinik Berchtesgadener Land (Other)
Overall Status
Completed
CT.gov ID
NCT02462343
Collaborator
(none)
26
2
5

Study Details

Study Description

Brief Summary

All measurements are performed on two consecutive days at the beginning of a pulmonary rehabilitation program in a randomized cross-over study design. On the first day, each patient is randomly assigned to perform either the 2 minute walk test or the 6 Minute walk test. On the second day each patient performs the test that was not performed on the first day. All walk tests are performed by the same investigator on the same track and time of day, following the 2002 guidelines of the American Thoracic Society.

Patients wear a mobile pulse oximeter that continuously records heart rate and oxygen saturation during testing. Baseline values of oxygen saturation, heart rate and ratings of perceived exertion on the modified Borg scale (0 to 10) for dyspnea and leg fatigue are recorded at rest after 10 minutes of sitting.

Condition or Disease Intervention/Treatment Phase
  • Other: walk tests
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
26 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
Comparison of the Two and Six- Minute Walk Tests in Evaluating Oxygen Desaturation in Patients With Severe COPD
Study Start Date :
Mar 1, 2007
Actual Primary Completion Date :
May 1, 2007
Actual Study Completion Date :
Aug 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Other: 2 minute walk test

Other: walk tests

Other: 6 minute walk test

Other: walk tests

Outcome Measures

Primary Outcome Measures

  1. oxygen desaturation [up to 6 minute walk test]

Secondary Outcome Measures

  1. heart rate [during 2 minute walk test and 6 minute walk test]

  2. perceived exertion for dyspnea and leg fatigue [during 2 minute walk test and 6 minute walk test]

    measured by a modified Borg scale from 0 to 10

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • confirmed diagnosis of chronic obstructive lung disease stage III or IV according to the Global Initiative for chronic Obstructive Lung Diseases definition

  • ability to read and understand the German language and study procedures.

  • written informed consent

Exclusion Criteria:
  • severe acute exacerbation of chronic obstructive lung disease

  • severe respiratory failure (partial Oxygen pressure at rest lower than 55 millimeter mercury)

  • non compliance to the study protocol.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Schön Klinik Berchtesgadener Land

Investigators

  • Principal Investigator: Klaus Kenn, MD, Schoen Klinik Berchtesgadener Land

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Klaus Kenn, MD, Schön Klinik Berchtesgadener Land
ClinicalTrials.gov Identifier:
NCT02462343
Other Study ID Numbers:
  • walk test trial
First Posted:
Jun 4, 2015
Last Update Posted:
Jun 4, 2015
Last Verified:
Jun 1, 2015

Study Results

No Results Posted as of Jun 4, 2015